HRP20090105T3 - Method for producing thiophene glycoside derivatives - Google Patents

Method for producing thiophene glycoside derivatives

Info

Publication number
HRP20090105T3
HRP20090105T3 HR20090105T HRP20090105T HRP20090105T3 HR P20090105 T3 HRP20090105 T3 HR P20090105T3 HR 20090105 T HR20090105 T HR 20090105T HR P20090105 T HRP20090105 T HR P20090105T HR P20090105 T3 HRP20090105 T3 HR P20090105T3
Authority
HR
Croatia
Prior art keywords
formula
compound
alkyl
previously defined
aryl
Prior art date
Application number
HR20090105T
Other languages
English (en)
Croatian (hr)
Inventor
Derdau Volker
Bierer Lars
Kossenjans Michael
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20090105T3 publication Critical patent/HRP20090105T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20090105T 2004-12-22 2005-12-08 Method for producing thiophene glycoside derivatives HRP20090105T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004063099A DE102004063099B4 (de) 2004-12-22 2004-12-22 Verfahren zur Herstellung von Thiophenglycosidderivaten
PCT/EP2005/013158 WO2006072334A2 (fr) 2004-12-22 2005-12-08 Procédé pour produire des dérivés de glucoside de thiophène

Publications (1)

Publication Number Publication Date
HRP20090105T3 true HRP20090105T3 (en) 2009-03-31

Family

ID=36599271

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090105T HRP20090105T3 (en) 2004-12-22 2005-12-08 Method for producing thiophene glycoside derivatives

Country Status (29)

Country Link
US (1) US20080207882A1 (fr)
EP (1) EP1888613B1 (fr)
JP (1) JP2008524272A (fr)
KR (1) KR20070089946A (fr)
CN (1) CN101080416A (fr)
AR (1) AR052272A1 (fr)
AT (1) ATE415407T1 (fr)
AU (1) AU2005324187A1 (fr)
BR (1) BRPI0519438A2 (fr)
CA (1) CA2591114A1 (fr)
CL (1) CL2008002563A1 (fr)
CY (1) CY1108819T1 (fr)
DE (2) DE102004063099B4 (fr)
DK (1) DK1888613T3 (fr)
ES (1) ES2318574T3 (fr)
HR (1) HRP20090105T3 (fr)
IL (1) IL183806A0 (fr)
MA (1) MA29111B1 (fr)
NO (1) NO20073213L (fr)
NZ (1) NZ555591A (fr)
PL (1) PL1888613T3 (fr)
PT (1) PT1888613E (fr)
RS (1) RS50726B (fr)
RU (1) RU2394835C2 (fr)
SI (1) SI1888613T1 (fr)
TW (1) TW200635940A (fr)
UY (1) UY29306A1 (fr)
WO (1) WO2006072334A2 (fr)
ZA (1) ZA200704028B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008002427A1 (es) 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
JP5685550B2 (ja) 2009-02-13 2015-03-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｇｌｔ２阻害剤、ｄｐｐ−ｉｖ阻害剤、更に必要により抗糖尿病薬を含む医薬組成物及びその使用
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL108748A0 (en) * 1993-02-23 1994-08-26 Univ Princeton Solution and solid-phase formation of glycosidic linkages
DE10231370B4 (de) * 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel

Also Published As

Publication number Publication date
JP2008524272A (ja) 2008-07-10
WO2006072334A3 (fr) 2007-06-07
IL183806A0 (en) 2007-10-31
BRPI0519438A2 (pt) 2009-01-20
TW200635940A (en) 2006-10-16
DE502005006107D1 (de) 2009-01-08
ZA200704028B (en) 2008-08-27
DE102004063099B4 (de) 2009-02-12
US20080207882A1 (en) 2008-08-28
AR052272A1 (es) 2007-03-07
DE102004063099A1 (de) 2006-07-13
DK1888613T3 (da) 2009-03-30
RU2007127840A (ru) 2009-01-27
UY29306A1 (es) 2006-07-31
CL2008002563A1 (es) 2009-01-02
NO20073213L (no) 2007-09-19
CA2591114A1 (fr) 2006-07-13
RU2394835C2 (ru) 2010-07-20
PT1888613E (pt) 2009-01-30
RS50726B (sr) 2010-08-31
AU2005324187A1 (en) 2006-07-13
PL1888613T3 (pl) 2009-04-30
CY1108819T1 (el) 2014-04-09
ES2318574T3 (es) 2009-05-01
KR20070089946A (ko) 2007-09-04
NZ555591A (en) 2009-07-31
ATE415407T1 (de) 2008-12-15
MA29111B1 (fr) 2007-12-03
CN101080416A (zh) 2007-11-28
WO2006072334A2 (fr) 2006-07-13
SI1888613T1 (sl) 2009-04-30
EP1888613B1 (fr) 2008-11-26
EP1888613A2 (fr) 2008-02-20

Similar Documents

Publication Publication Date Title
CN104230795B (zh) 吡喃酮和吡啶酮衍生物的制备方法
Yanagihara et al. Chiral host-guest interaction. A water-soluble calix [4] resorcarene having L-proline moieties as a non-lanthanide chiral NMR shift reagent for chiral aromatic guests in water
Govindachari et al. Chemical constituents of Cleistanthus collinus (Roxb.)
CA2543820A1 (fr) Methodes de synthese de composes de quinolinone
MX9703548A (es) Proceso para purificar y aislar 2'-desoxi-2',2'-difluoronucleosidos.
WICHMANN et al. L-671, 329, A NEW ANTIFUNGAL AGENT II. STRUCTURE DETERMINATION
CA2539975A1 (fr) Analogues de 9,10-.alpha.,.alpha.-oh-taxane et procedes de fabrication correspondants
HRP20090105T3 (en) Method for producing thiophene glycoside derivatives
JPH01502749A (ja) エクテインアシジン７２９、７４３、７４５、７５９ａ、７５９ｂおよび７７０
SU886749A3 (ru) Способ получени 4-дезокси-4-амино-эритромицина а
DE112007001452A5 (de) Verfahren zur Herstellung von wasserstoffreichen Cyclosiloxanen
TW200611916A (en) High molecular compound, positive type resist composition and process for forming resist pattern
KR920021502A (ko) α-디아조-β-케토 에스테르 단위 및 설포네이트 단위를 함유하는 다작용성 화합물, 이의 제조방법 및 이의 용도
CN103664736A (zh) 一种含丙烯酰胺基吲哚的酯类衍生物及其制备方法和应用
EP4556031A3 (fr) Compositions pour la chélation de métaux à basses températures
DE60009517T2 (de) A-500359-derivate
DE502004006713D1 (de) Verfahren zur Herstellung alkoxidreiner Magnesiumalkoxide
SE8305538D0 (sv) Polysilylerat kanamycin a eller b som mellanprodukt vid framstellning av derivat av kanamycin a och b
Pawar et al. Antibacterial and antioxidant properties of macrocyclic Schiff bases with vanadium (V) complexes
US4939254A (en) Template synthesis of macrocyclic catecholamide complexes
YU35997A (sh) Postupak za pripremanje paklitaksela
Travagin et al. First synthesis of orthogonally 1, 7-diprotected cyclens
JP2008512451A5 (fr)
RU2002124772A (ru) Плюрафлавины и их производные, способ их получения и их применение
CN120484020A (zh) 抑制冠状病毒的β-核苷类化合物及其合成和应用